Tolerance and cross-tolerance to the antinociceptive effects of oxycodone and the imidazoline I-2 receptor agonist phenyzoline in adult male rats

摘要

Emerging evidence suggests the potential utility of combining opioids with imidazoline I-2 receptor agonists for chronic pain. However, chronic pain management requires prolonged pharmacotherapy, and the consequence of such combination therapy remains unclear.